These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12224817)

  • 41. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.
    Tikellis C; Bialkowski K; Pete J; Sheehy K; Su Q; Johnston C; Cooper ME; Thomas MC
    Diabetes; 2008 Apr; 57(4):1018-25. PubMed ID: 18235039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes.
    Sharma JN; Al-Shoumer K; Matar KM; Madathil NV; Al-Moalem A
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):240-6. PubMed ID: 25964383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical activity - related changes in ADMA and vWF levels in patients with type 2 diabetes: A preliminary study.
    Fiodorenko-Dumas Z; Dumas I; Mastej K; Adamiec R
    Adv Clin Exp Med; 2017 Jul; 26(4):601-608. PubMed ID: 28691426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition.
    Goel R; Bhat SA; Rajasekar N; Hanif K; Nath C; Shukla R
    Pharmacol Biochem Behav; 2015 Jun; 133():132-45. PubMed ID: 25869103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
    Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT
    Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
    Fogari R; Mugellini A; Zoppi A; Corradi L; Preti P; Lazzari P; Derosa G
    Am J Hypertens; 2002 Apr; 15(4 Pt 1):316-20. PubMed ID: 11991216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
    Zhang WR; Chen BM; Xiong Y; Tao LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):57-9. PubMed ID: 15871189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes].
    Inzhutova AI; Salmina AB; Petrova MM
    Kardiologiia; 2007; 47(8):49-52. PubMed ID: 18260912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [NO and hypertension].
    Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():243-6. PubMed ID: 15171377
    [No Abstract]   [Full Text] [Related]  

  • 57. Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction.
    Hsu CN; Lee CT; Huang LT; Tain YL
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):506-13. PubMed ID: 24833625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
    Candido R; Jandeleit-Dahm KA; Cao Z; Nesteroff SP; Burns WC; Twigg SM; Dilley RJ; Cooper ME; Allen TJ
    Circulation; 2002 Jul; 106(2):246-53. PubMed ID: 12105166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.